معرفی
Michael B. Yaffe is the David H. Koch Professor of Science and Professor of Biology and Biological Engineering at MIT, where he has been a faculty member since 2000. He serves as Director of the MIT Center for Precision Cancer Medicine and the KI Clinical Investigator Program. Clinically, he is an attending surgeon and intensivist at Beth Israel Deaconess Medical Center, specializing in injury and surgical oncology.
- Education: MD-PhD from Case Western Reserve University
- Training: Residency at University Hospitals of Cleveland; Fellowship at Harvard-Longwood Critical Care Program
Dr. Yaffe's research focuses on protein kinase signaling pathways activated by DNA damage, cell injury, and inflammation. His work explores how these pathways regulate cancer behavior and treatment response through integrated experimental and computational approaches, with translational applications in systems pharmacology and precision medicine.
His 15 most recent publications span DNA damage responses, mitotic stress, immunogenic cell injury, kinase signaling atlases, and reproducibility in science. Key trends include targeting pathway crosstalk for therapeutic synergy, leveraging R-loops in DNA repair-deficient tumors, and understanding immune activation post-chemotherapy.
Scientific Awards:
- HHMI Physician-Scientist Fellowship
- Burroughs-Wellcome Fund Award
- MacVicar Faculty Fellow (2021)
- Association of American Physicians (2021)
- American Surgical Association membership
Dr. Yaffe advises trainees in scientific career development and leads the Yaffe Lab at MIT, which pioneers novel technologies like peptide libraries and multiplex kinase reporters. His work bridges benchtop experiments with clinical applications in chemotherapy, radiation, and surgery, while also addressing inflammation-cancer connections.
